Related Experiment Video
Updated: Jun 15, 2026

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Amyloid heart disease
Simon W Dubrey1, Rodney H Falk
1Department of Cardiology, Hillingdon Hospital, Uxbridge Middlesex.
Insights
Early recognition of cardiac amyloidosis is crucial for better patient outcomes. Delayed diagnosis leads to severe heart compromise and necessitates aggressive treatments, impacting survival.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Amyloidosis Research
Background:
- Cardiac amyloidosis can lead to severe heart complications.
- Outcomes are influenced by amyloid type, disease extent, and treatment availability.
- Late diagnosis is associated with poor prognosis due to advanced cardiac compromise.
Purpose of the Study:
- To highlight the critical impact of timely diagnosis in cardiac amyloidosis.
- To underscore the relationship between diagnostic delay and patient outcomes.
- To emphasize the challenges posed by late-stage disease and aggressive treatment requirements.
Main Methods:
- This study is a review of existing literature on cardiac amyloidosis.
- Analysis of clinical consequences based on disease recognition timing.
- Evaluation of treatment implications in relation to disease severity.
Main Results:
- Delayed recognition of cardiac amyloidosis correlates with significantly poorer patient outcomes.
- The severity of cardiac compromise is a key factor in determining prognosis.
- Aggressive treatment strategies are often required in late-stage presentations.
Conclusions:
- Timely diagnosis and intervention are paramount in managing cardiac amyloidosis.
- Prognosis is heavily dependent on the stage at which the disease is identified.
- Further research into earlier detection methods is warranted to improve patient survival.
Abstract:
Heart involvement can have devastating consequences. The clinical consequences will depend on the type of amyloid, the extent of systemic involvement and treatment options. Patients in whom disease recognition is late have poor outcomes, because of the severity of cardiac compromise and the necessarily aggressive treatments.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction

